CNTX - Context Therapeutics Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.38 -0.03 (-2.17%)	---	0.0 (0.0%)	0.0 (0.0%)	-0.03 (-2.17%)	-0.03 (-2.17%)	0.0 (0.0%)	0.0 (0.0%)

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -15.0
Diluted P/E:: -15.0
RSI(14) 1m:: 100.0
VWAP:: 1.35
RVol:: 2.0808

Events

Period	Kind	Movement	Occurred At
Day	Rvol 2 increase day	rvol 2.02, 1.35 -0.03 (-2.54%)	Oct 15 15:54
1m	Price decrease 1m	1.35 -0.02 (-1.1%)	Oct 15 15:54
1m	Price decrease 1m	1.36 -0.03 (-2.26%)	Oct 15 14:40
1m	Price increase 1m	1.38 +0.02 (+1.47%)	Oct 15 14:30
10m	Price increase 10m	1.38 +0.04 (+3.23%)	Oct 15 14:28